Radiation-Induced Heart Disease
Cancer incidence and survivorship have had a rising tendency over the last two decades due to better treatment modalities. One of these is radiation therapy (RT), which is used in 20–55% of cancer patients, and its basic principle consists of inhibiting proliferation or inducing apoptosis of cancer...
Main Authors: | Juan A. Quintero-Martinez, Sandra N. Cordova-Madera, Hector R. Villarraga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/1/146 |
Similar Items
-
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy
by: Anthony F. Yu, et al.
Published: (2023-03-01) -
Cardio-oncology: what you need to know now for clinical practice and echocardiography
by: Carolyn M Larsen, et al.
Published: (2017-04-01) -
Valvular Heart Disease following Anthracycline Therapy—Is It Time to Look beyond Ejection Fraction?
by: David Zahler, et al.
Published: (2022-08-01) -
Evolving field of cardio-oncology
by: Guo Li, et al.
Published: (2023-04-01) -
Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry)
by: Keiko Inoue, et al.
Published: (2021-03-01)